Galectin's MASH treatment reduces varices but fails to hit statistical significance in phase 3 trial  Fierce Biotech

Clinical research company Javara lays off employees as part of restructuring  Fierce Biotech

Applied Therapeutics CEO steps down in wake of FDA rejection, warning letter and investor lawsuit  Fierce Biotech

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision  Fierce Biotech

Apollomics, after giving up on GlycoMimetics' leukemia therapy, posts drug's latest phase 3 fail  Fierce Biotech

ElectroCore to buy NeuroMetrix and its Quell fibromyalgia wearable stimulator  Fierce Biotech

FDA's principal deputy to depart agency—Chutes & Ladders  Fierce Biotech

Novo Nordisk stock crashes after CagriSema misses phase 3 weight-loss goal  Fierce Biotech

Pyxis Oncology shelves antibody to focus on sole clinical asset, an ADC licensed from Pfizer  Fierce Biotech

Aadi pulls commercial-to-preclinical pivot, buying ADCs and selling approved drug to reboot business  Fierce Biotech

FDA rejects Zealand Pharma's GLP-2 analog in rare bowel disease  Fierce Biotech

Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies  Fierce Biotech

Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection  Fierce Biotech

BMS pays Leqembi originator $100M for next-gen preclinical Alzheimer's prospects  Fierce Biotech

Roche reports failure of Prothena-partnered Parkinson's prospect in phase 2b but highlights positives  Fierce Biotech

Labcorp launches bird flu test amid first severe case in the US  Fierce Biotech

Ring Therapeutics lays off just under half of staff in 2nd wave of cuts this year, CEO set to step down  Fierce Biotech

Alphabet spinoff SandboxAQ raises $300M fund for 'next wave of AI'  Fierce Biotech

mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain  Fierce Biotech

Novartis, BioAge take on age-related diseases in $550M pact  Fierce Biotech

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara  Fierce Biotech

Roche to bring mass spec to routine labs with new cobas system’s European approval  Fierce Biotech

Holoclara wriggles roundworm-derived molecule into phase 1, targeting eosinophilic esophagitis  Fierce Biotech

Novo Nordisk taps Photys for $186M cardiometabolic collab  Fierce Biotech

Novo Holdings leads SiteOne's $100M series C for non-opioid pain treatments  Fierce Biotech